全基因组关联研究
单核苷酸多态性
DNA甲基化
CpG站点
SNP公司
遗传学
甲基化
表观遗传学
哮喘
人口
遗传关联
医学
生物
基因
内科学
基因型
基因表达
环境卫生
作者
Ashish Kumar,Cilla Söderhäll,Simon Kebede Merid,Cheng‐Jian Xu,Olena Gruzieva,Gerard H. Koppelman,Juha Kere,Göran Pershagen,Erik Melén
标识
DOI:10.1183/13993003.congress-2016.pa1209
摘要
Background: Asthma is characterized as a chronic inflammation disease and has increased in prevalence over the decades. Genome-wide association studies (GWAS) have implicated several single nucleotide polymorphisms (SNPs) with varying risk estimates for asthma, but the etiology is still not fully understood. Objective: To investigate the association between genetic and epigenetic (methylation) variations in six common GWAS asthma genes - ORMDL3, GSDMB, IL1RL1, IL4R, TSLP and WDR36, we explored the cis and trans-regulatory effects to identify SNPs associated with altered DNA methylation (meQTL) in 500kb buffer region and how top GWAS SNPs relate with resulting SNP-CpG hits. Methods: Using peripheral blood of 231 eight-year-old children with a doctor9s diagnosis of asthma ever and 233 controls, from the BAMSE study, DNA methylation was measured on Illumina 450K beadchip and SNPs were assessed on Illumina610-Quad beadchip, imputed on 1000 Genomes reference panels. To identify meQTLs, CpG methylation values were regressed on SNP dosages with sex, asthma status and population stratification eigenvalues as covariates. Results: After applying genome-wide Bonferroni significance thresholds, we had significant SNP-CpG pair hits. The top hits for ORMDL3/GSDMB was cg26162295-rs8081462 (p=4.89x10-50) while LD with GWAS top SNP rs7216389 is r2=0.46. Similarly for IL1RL1, cg09003973-rs11902044 was top hit (p=5.76x10-32) and for TSLP, cg13681701-rs35188965 was top hit (p=4.47x10-71), with no LD to their top GWAS SNPs ( r2<0.05) Conclusion: Our results indicate that most CpG sites were associated with SNPs manifesting cis-effects. Thus, studying these meQTLs can help us disentangle some of the molecular mechanisms of asthma better.
科研通智能强力驱动
Strongly Powered by AbleSci AI